Skip to main content

ETHNOS_APP

Home • Search • Journals • List 0

Application of oXiris-continuous hemofiltration adsorption in patients with sepsis and septic shock

A single-centre experience in China

Bibliographic Data

ID22083074
AuthorsYanyan Zhou (0000-0002-3343-9664, Central South University), Chenfang Wu (0000-0001-9579-4496, Central South University), Lin Ouyang (0000-0002-4109-9874, Central South University), Ying Peng (0000-0002-8801-5711, Central South University), Dingming Zhong (Central South University), Xiaohong Xiang (0000-0002-9020-9187, Central South University), Jinxiu Li (0000-0002-9479-8230, Central South University, corresponding author)
Year2022
Volume10
Pages1012998-1012998
Publication date2022-09-29
Open AccessYes
TypeARTICLE
VenueFrontiers in Public Health (JOURNAL)
Journal identifiersISSN: 2296-2565 • E-ISSN: 2296-2565
PublisherFrontiers Media SA (PUBLISHER • CH)
DOI10.3389/fpubh.2022.1012998
PMID36249210
OpenAlexW4297999723
LanguageEN
References cited54

oXiris is a new, high-adsorption membrane filter in continuous hemofiltration adsorption to reduce the inflammatory response in sepsis. The investigators retrospectively reviewed patients with sepsis/septic shock who underwent at least one oXiris-treatment from November 2020 to March 2022. The demographic data, baseline levels before treatment, clinical datas, prognosis, and the occurrence of adverse events during treatment were recorded. 90 patients were enrolled in this study. The hemodynamic indices, sequential organ failure assessment score, lactate, inflammatory biomarkers levels were significantly improved at 12 h and 24 h after treatment. Procalcitonin and interleukin-6 reduction post-treatment of oXiris were most pronounced in infection from skin and soft tissue, urinary and abdominal cavity. Logistic regression analysis showed that pre-treatment sequential organ failure assessment score ( p = 0.034), percentage decrease in sequential organ failure assessment score ( p = 0.004), and age ( p = 0.011) were independent risk factors for intensive care unit mortality. In conclusion, oXiris-continuous hemofiltration adsorption may improve hemodynamic indicators, reduce the use of vasoactive drugs, reduce lactate level and infection indicators. Of note, oXiris improve organ function in sepsis, which may result to higher survival rate

Hemodialysis · Hemofiltration · Intensive care medicine · Intensive care unit · Logistic regression · Procalcitonin · Renal function · Sepsis · Septic shock · Hemodynamic Monitoring and Therapy · Intensive Care Unit Cognitive Disorders · Medicine · Sepsis Diagnosis and Treatment · Internal Medicine

  • The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3)

    Mervyn Singer, Clifford S Deutschman et al.•JAMA•2016

  • Global, regional, and national sepsis incidence and mortality, 1990–2017

    Open Access•Kristina E Rudd, Sarah C Johnson et al.•The Lancet•2020

Highly citedNo

Tools

Open DOIOpen Access
Ethnos_APP • Open Source Project • MIT License • Frontend v2.0.0 • Privacy and Cookies • API Documentation: api.ethnos.app/docs • API Source Code: GitHub • DOI: 10.5281/zenodo.17049435 • Frontend Source Code: GitHub • DOI: 10.5281/zenodo.17050053 • cruz.rio.br • Expectantes Misericordiae